lunes, 18 de noviembre de 2024

Revumenib Approved for R/R Acute Leukemia With KMT2A Translocation M. Alexander Otto November 18, 2024

https://www.medscape.com/viewarticle/revumenib-approved-r-r-acute-leukemia-kmt2a-translocation-2024a1000kzc

No hay comentarios:

Publicar un comentario